Begin main content

New Members Appointed to CADTH Expert Committees

October 2, 2017
Dr. Brian O’Rourke, CADTH President and Chief Executive Officer, is pleased to announce the appointment of four new members and a new chair to Canadian Drug Expert Committee (CDEC), and two new members and a new chair to its Health Technology Expert Review Panel (HTERP). Canadian Drug Expert Committee Dr. James Silvius, Associate Professor in th...

CADTH Recognition Awards — Nominations Now Being Accepted

October 2, 2017
We are pleased to announce that nominations are now being accepted for the Dr. Maurice McGregor Award and Dr. Jill M. Sanders Award of Excellence in Health Technology Assessment, two prestigious awards for outstanding achievement in the field of health technology assessment in Canada. Submit your nominations by January 19, 2018. Travel Award De...

CDR Update 128

September 28, 2017
See CDR Update 128 for important news and information regarding the CADTH Common Drug Review.

Call for Patient Input: Admelog and Ocrevus

September 27, 2017
CADTH has received the following drug submission(s) and/or notice(s) of pending submission(s). If you are interested in providing patient input, please click on “Submit.” For information about the patient input process or for additional instructions, please see the Patient Input page of our website. Admelog Brand name Generic name Manufacturer I...

Call for Patient Input: Monoprost

September 26, 2017
CADTH has received the following drug submission(s) and/or notice(s) of pending submission(s). If you are interested in providing patient input, please click on “Submit.” For information about the patient input process or for additional instructions, please see the Patient Input page of our website. Monoprost Brand name Generic name Manufacturer...